SEARCH:   Advanced

Blood, Vol. 109, Issue 12, 5164-5167, June 15, 2007 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study Blood Whitman et al. 109: 5164 Supplemental materials for: Whitman et al, Vol 109, Issue 12, 5164-5167 Files in this Data Supplement: Document 1. Cancer and Leukemia Group B institutions, principal investigators, and cytogeneticists who participated in this study (PDF, 15.9 KB) Table S1. Therapy and clinical outcome in the current and previously reported studies analyzing adults with CN-AML and MLL-PTD (PDF, 36.5 KB) Figure S1. Disease-free survival of CN-AML patients with MLL-PTD according to additional molecular marker status (PDF, 22 KB) - A. Expression of the BAALC gene. B. The presence or absence of FLT3-ITD. C. The presence or absence of a mutation in the NPM1 gene. D. Expression of the ERG gene. This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020